Transgene expands myvac platform into non-small cell lung cancer with TG4070

Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB

Bavarian Nordic secures DKK700m government vaccine contract

Anixa secures Canadian patent milestone for ovarian cancer vaccine

Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases

4basebio secures clinical supply agreement for Phase II immunotherapy trial

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49

Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook

Anixa Biosciences reports extended survival signals in Phase 1 ovarian cancer CAR-T trial

4basebio introduces enzymatic ssDNA platform for gene editing applications

WuXi Biologics announces structural completion and key equipment arrival at Chengdu microbial manufacturing site

hVIVO secures Phase III human challenge trial contract with ILiAD Biotechnologies

Sanofi's Nuvaxovid demonstrates superior tolerability to Moderna's mNEXSPIKE in phase 4 study

hVIVO signs influenza human challenge trial agreement with Traws Pharma

Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104